Results 31 to 38 of about 45 (38)

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C

Journal of Hepatology, 2004
Graham Cooksley, George Marinos, Ming-Yang Lai   +2 more
exaly  

Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

American Journal of Health-System Pharmacy, 2005
Jon D Herrington, Ralph V Boccia
exaly  

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

New England Journal of Medicine, 2009
Eric J Lawitz, Jonathan Mccone, Mitchell N Davis   +2 more
exaly  

Darbepoetin Alfa

Drugs, 2012
Tim Ibbotson, Karen L Goa, Goa Karen L
exaly  

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Lancet, The, 2005
Harry La Janssen, Monika van Zonneveld, Ulus S Akarca   +2 more
exaly  

All-cellulose composites from alfa and wood fibers

Industrial Crops and Products, 2019
Khaled Labidi, Montassar Zrida, Tatiana Budtova   +2 more
exaly  

The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease

Current Medical Research and Opinion, 2006
Pierre-Yves Crémieux, Patrick Lefebvre   +1 more
exaly  

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Blood, 2019
Abdulraheem Yacoub, John Mascarenhas, Josef T Prchal   +2 more
exaly